Biologically active alkali metal complexones. A 13C-NMR study of ion—dipole interaction  by Bystrov, V.F. et al.
Volume 2 1, number 1 FEBS LETTERS March 1972 
BIOLOGICALLY ACTIVE ALKALI METAL COMPLEXONES. 
A I3 C-NMR STUDY OF ION-DIPOLE INTERACTION 
V.F. BYSTROV”, V.T. IVANOV, S.A. KOZ’MIN, 1.1. MIKHALEVA, 
KKH. KHALILULINA and YU.A. OVCHINNIKOV 
Shemyakin Institute for Chemistry of Natural Products, 
USSR Academy of Sciences, Ul, Vavilova 32. Moscow V-312, USSR 
E.I. FEDIN and P.V. PETROVSKII 
Institute of Organoelement Compounds, USSR Academy of Sciences, Moscow, USSR 
Received 24 December 197 1 
1. Introduction 
The recently discovered ability of cyclic depsipep 
tides and peptides to form stable alkali ion complexes 
(see [ 1 ] and ref. therein) has aroused considerable 
interest. Such compounds are being widely used as 
tools for the study of processes associated with ion 
transport through membranes. They are also con- 
venient models for investigating the binding of Na+ 
and K’ ions in biological systems. Among the most 
popular of the alkali metal complexones are the depsi- 
peptide antibiotics valinomycin and the enniatins, and 
the cyclic decapeptide antamanide [ 2,3] . A character- 
istic feature of valinomycin is its exceptionally high 
K’/Na’ selectivity; the enniatins are less selective 
[ 1,4] , whereas antamanide displays selectivity for 
the Na’ ion [4, 51 
Important information on the spatial structure and 
complexing mechanism of the above compounds in 
solution has been obtained by proton magnetic reson- 
ance spectroscopy [6- 121 . It is to be expected that 
the intensively developing field of ‘3C-nuclear-mag- 
netic-resonance will open up new possibilities in such 
studies and that it will become a powerful new method 
among the physicochemical techniques used for in- 
vestigating three-dimensional structures. For peptidic 
compounds data have already accumulated permitting 
assignment of the ‘3C-signals to the principal structur- 
* To whom to address all correspondence. 
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al elements [ 13-191 . However, correlations are still 
lacking that would allow the use of this method in 
conformational analysis [ 161 . 
The present paper compares the 13C-spectra of 
vahnomycint l(D-Val-L-Lac-L-Val-D-HyIv)sJ 
[6, 121, of beauvericin l(L-MePhe-D-HyIv),j 
[20,21] an antibiotic belonging to the enniatin series, 
and a symmetric analog of antamanide (Va16, Ala’- 
antamanide [22-241 
4L_Val-L-Pro-L-Pro-L-Ala-L-Phe)2 1 
1,6 2,7 3,8 4,9 5,lO 
with those of their alkali metal (Na+, K’) complexes. 
Beauvericin stands very close in conformational para- 
meters and complexing properties to the thoroughly 
investigated enniatin antibiotics [9, 21, 231, while 
the symmetric antamanide analog is very similar to 
the naturally occurring cyclopeptide [ 11, 22, 23,251 
2. Experimental 
The r3C-spectra were obtained at 22.63 MHz on a 
Bruker HX 90/ 13- 18” spectrometer equipped with a 
Fabri-Tek 1085 computer (20K core memory). The 
spectrometer was operated in the Fourier-transform 
t The following abbreviations for residues are used: 
Hylv: o;-hydroxyisovaleric acid; MePhe, N-methylphenylalan- 
ine; Lac, lactic acid 
North-Holland fiblishing Company - Amsterdam 
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Fig. 1. Spatial structure of the K+ complex of valinomycin. 
mode with multiple scanning (2000-8000 scans at 
0.8 set/scan) and proton noise decoupling at 90 MHz. 
Solutions of 100-300 mg of substance in 1.4 ml of 
a 1: 1 (v:v) mixture of CDCla with CDs OD were used. 
The complexes were formed by adding excess KNCS 
or NaNCS in 1:2.5 mole ratios for valinomycin and 
I:5 mole ratios for beauvericin and “symmetric” an- 
tamanide. The chemical shifts (+ 0.2 ppm) were mea- 
sured with respect to CS2 (0.07 ml) as internal refer- 
ence. 
A biosynthetic sample of valinomycin [26] was 
used whereas beauvericin [21] and “symmetric” an- 
tamanide [24] were prepared by total synthesis. 
Assignment of the 13C-peaks was made on the 
basis of data for amino acids and dipeptides [ 13-191 
and also by comparison of the spectra of the com- 
pounds among themselves. 
3. Results and discussion 
It had earlier been shown [ 1,6,9,11, 12, 22,23, 
27, 281 that the distinctive characteristic of the com- 
plexes in question is the location of the ion within the 
central cavity of the cyclic molecule so that the for- 
Table 1 
i3C-chemical shifts of valinomycin and its K+ complex. 
Carbon 
c=o 
Valinomycin K’ complex 
20.4 16.8 
20.9 17.3 
21.7 19.8 
22.3 21.2 
co-o 
HyIv 113.9 112.7 
Lac 122.1 121.3 
Cff-N 
133.0 130.6 
134.0 130.8 
162.2 162.3 
Cp-H 163.1 164.2 
163.5 164.2 
173.6 172.6 
173.6 172.6 
173.8 173.2 
a3 174.0 173.7 
174.0 173.9 
175.8 175.3 
173.1 175.9 
Signals from solvents 
CDqa 114.9 
CD30Db 
114:8 
114.3 114.3 
a Deuterium isotope shift +0.17 ppm, JCD = 32.3 Hz. 
b JCD (CD31 = 2 1.5 HZ. 
mer is held in place by ion-dipole interaction with 
those carbonyls that are oriented towards the center 
of the cavity. 
It was to be expected that with ion -dipole inter- 
action of the type C=O...M+, where M stands for the 
monovalent cation (Na’ or K+) an additional shift of 
electron density on the carbonyl bond towards the oxy- 
gen will take place. This should decrease the r3C- 
screening only of those carbonyls that are sufficiently 
near to the cation. 
With valinomycin we have the following: there are 
4 13C=0 signals (see fig. 1) of which, owing to sym- 
metry of the chemical and spatial structures of the 
molecule, each should correspond to the carbonyls 
of 3 identical ammo or hydroxy acid residues. Now, 
in the spectrum of the K+ complex only one r3C=0 
signal falls within the C=O region of the non-com- 
plexed valinomycin spectrum (table 1). But since, 
35 
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Fig. 2. 13C-NMR spectra of valinomycin (a) and of its K+ complex (b) in CDC13-CD30D (1: 1, v:v) solution. Concentration 
300 mgJ1.4 ml; 2024 scans; repetition time: 0.8 set, time of accumulation: 27 min. 
from the spatial structures of the complexed and non- 
complexed molecules [6, 12, 271 , it follows that com- 
plexing should similarly affect the 2 ester C=O sig- 
nals and similarly the 2 amide C=O signals, it also 
follows that all the r3 C=O resonances (including the 
one remaining in the non-complexed valinomycin 
region) must have undergone a paramagnetic shift as 
the result of the complexing. 
The shifts of the signals belonging to 6 l3 C=O 
groups are quite considerable (3.1-5.5 ppm). These 
must be assigned to the ester carbonyls which, as had 
been earlier established [6, 12,271, are engaged in 
strong ion-dipole interaction with the K’ ion located 
in the molecular cavity. However, the shifts of the 
other 2 (amide) signals are also quite noticeable 
(0.5-l 9 ppm downfield). This means that, as well as 
taking part in hydrogen bonding [6, 12,271 these 
carbonyls may also be participating in weak ion-di- 
pole interaction with the K’ ion (here the 0.. .K’ dis- 
tance is around 4.0-4.5 A). 
In conformity with the theory of magnetic screen- 
ing associated with electrostatic bond polarization 
[ 15,29,30] it follows that the induced chemical 
shift should decrease with decrease in the C=O...M’ 
angle from 180” to 90”. In enniatin complexes where 
all 6 carbonyls are symmetrically located around the 
central cation [ 1,9,28] , these angles are much less 
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than 180” (in contrast with valinomycin where these 
are approx. 180” [6, 12,271). Hence, despite the 
practically identical 0 . . .K’ distance (2.7-2.9 A) in 
both types of complexes, the change in l3 C=O re- 
sonance should be less for the enniatins. In fact, in 
the K+ complex of beauvericin the ” C=O signal 
undergoes less change in position than in the valino- 
mycin complex. 
When the K+ cation is replaced by the smaller Na’ 
cation a characteristic change occurs in the enniatin 
conformation, similar to the closing of a flower [ 1,9] 
This is connected with decrease in the 0.. .M+ distance 
and a straightening out of the C=O...M’ angle 
causing an increase in the positive charge electrical 
field component directed along the carbonyl bond. 
As a result the l3 C=O resonance for the Na’ com- 
plex of beauvericin shifts by 1.7 and 2.3 ppm to 
lower field (table 2). 
In the r3C-spectrum of “symmetric” antamanide 
complex with Na+ a significant shift to lower field 
(- 2.3 ppm) is observed for only one I3 C=O line 
corresponding to 2 symmetrically located identical 
amino acid residues (table 3). The resonances of the 
other 4 C=O signals are within the limits of only 
-1.5 to +0.5 ppm. Hence the carbonyls of only 2 
identical amino acid residues (apparently Val’ and 
Va16) of the cyclodepsipeptide residue approach the 
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Table 2 
13C-chemical shifts of beauvericin and its 
complexes with K+ and Na+ ions. 
Carbon Beauvericin K+ 
complex 
c=o 21.6 20.2 
22.9 20.9 
&Cp) MePhe 56.3 56.4 
C- ortho 64.1 63.9 
C- meta 64.1 64.3 
C- para 65.8 65.4 
c?- 0 HyIv 116.8 115.8 
Co-N MePhe 136.2 135.3 
CP MePhe 158.2 158.9 
CO HyIv 161.3 161.3 
N-CH3 MePhe 162.8 162.7 
CH3 HyIv 174.4 175.4 
176.1 175.5 
Signals from solvants 
Nd 
complex 
19.9 
20.6 
56.5 
63.9 
64.3 
65.5 
* 
135.3 
159.6 
161.4 
163.1 
175.4 
175.6 
CDC13 115.1 115.0 115.1 
CD30D 144.3 144.3 144.2 
* Hidden by CD& multiplet. 
cation located within the internal cavity of the cyclo- 
depsipeptide. This conclusion is in complete agree- 
ment with the earlier proposed conformation of the 
Na*-antamanide complex [ 11,221 of which only 
the 2 carbonyls of the symmetrically situated Val’ 
and Phe6 residues are in close contact (- 2.6 ii) with 
the central ion. 
Besides the ion-dipole interaction induced shifts 
of the 13C=0 signal discussed above, marked changes 
are observed also in the position of a number of other 
signals. For instance, both signals from the C-N 
atom of valinomycin are shifted by 2.1-3.4 ppm to 
low field on complex formation, whereas the P-0 
signal is shifted by only -1.2 and -0.8 ppm (table l), 
Obviously such selective shifts are due to conforma- 
tional rearrangement of the molecule on complex 
formation. 
13C-NMR-spectroscopy presents new wide possibil- 
Table 3 
‘3C-chemical shifts of Va16, Alag-antamanide and 
its Na+ complex. 
Carbon Va16, Ala’- 
antamanide 
Na+ complex 
c=o 
&(c?) Phe 
C-ortho 
C-meta 
C-para 
Pro 
Pro 
Ca Val 
Ala > 
Phe 
ca Pro 
@ Phe 
Val 
8, fl Pro 
Ala 
cfJ3 Val 
Val 
Signals from solvents 
19.0 16.7 
20.8 19.3 
21.5 21.0 
21.5 21.7 
21.8 22.1 
54.4 56.2 
62.7 63.1 
64.5 62.3 
66.5 65.0 
131.9 133.1 
134.1 133.6 
136.1 136.6 
136.4 138.4 
142.5 140.6 
145.0 144.6 
146.0 145.4 
158.5 156.8 
161.2 160.3 
162.7 160.3 
164.6 163.7 
168.2 167.1 
171.0 170.1 
173.9 173.6 
175.4 174.2 
175.4 176.0 
cDc13 115.2 114.8 
CD3 OD 144.6 144.0 
ities for studying both the secondary and the tertiary 
structures of peptide and depsipeptide systems. Parti- 
cular stress is to be placed on the considerably higher 
“resolving power” of 13C-magnetic resonance than of 
proton resonance. For instance, in the 13C-spectra of 
“symmetric” antamanide and its Na’ complex indivi- 
dual signals are clearly visible from all of the 25 struc- 
turally non-equivalent carbon atoms. Evidently the 
main difficulty that can be seen so far is assignment 
of the ‘3C-signals, in particular those of the carbonyl 
37 
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groups. This can, of course, be overcome by synthesis [ 131 W.J. Horsley and HSternlicht, J. Amer. Chem. Sot. 90 
of compounds selectively labelled with 13C. (1968) 3738. 
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